The Terrible, Horrible, No Good, Very Bad Pharma Day* A challenge You are passionate about providing an intervention (drug or device) to a group… September 29, 2015 Uncategorized
(Re)Reading This Weekend (6/14/14) There were a few long reads that I'll be re-reading over the weekend, including: New… June 14, 2014 Uncategorized
Risk Distribution & Opportunity Costs in Entrepreneurship Risk Distribution In WIRED, "One Startup’s Struggle to Survive the Silicon Valley Gold Rush"… May 23, 2014 Uncategorized
R&D Scientists: Welcome to Your Contract This tweet recently caught my eye. (I'm assuming pharma here is drug related, including… March 21, 2014 Uncategorized
Partnering Tidbits from Turin I've escaped the cube farm long enough to share a few thoughts from BIO-Europe… March 11, 2014 Uncategorized
Personal Risk & Social Media in Pharma/Biotech Benefit: Something that promotes or enhances well-being Risk: the possibility of suffering harm or… March 4, 2014 Uncategorized
Social Media & Cancer Drugs: Conversation, not Promotion *This post was originally posted at Xconomy.* (Updated to include Lilly COI in table based… January 23, 2014 Uncategorized
Ringing in the New Year, Biotech Style The biotech New Year is being ushered in next week at the 31st Annual… January 3, 2013 Uncategorized
Drug Development & the User Experience What is Tech UX? I was recently at a local event for entrepreneurs (thanks… December 7, 2012 Uncategorized
Could Pharma U Fill A Gap? How can scientists successfully transition from academia to industry? This question has come to… September 26, 2012 Uncategorized